Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- ASAN -27.8% (also announces CEO is transitioning to Chair when new CEO begins), KSS -15.9%, RDW -13.3%, DAL -7.7%, AVO -6.9%, FERG -6.6%, MYPS -5.3%, AAL -3.7% (guidance), DKS -3.3%
Other news:
- ARVN -41.1% (Arvinas and Pfizer (PFE) announce topline results from Phase 3 VERITAC-2 clinical trial)
- CTRE -6.2% (agrees to $817 mln acquisition of Care REIT plc)
- UAL -5.4% (lower in sympathy with DAL)
- KOD -4% (completes enrollment in trial of tarcocimab)
- LCII -3.2% (intends to offer $400.0 mln in aggregate principal amount of convertible senior notes due 2030)
- FISI -2.6% (setles auto lending litigation)
- PCOR -1.5% (CEO to transition to Executive Chairman; reiterates guidance)
- ULCC -1.2% (lower in sympathy with DAL)